During the trans differentiation of prostate adenocarcinoma to NEPC, PCa cells lose AR or AR-regulated gene expression, while gaining neuroendocrine markers like neuro-specific enolase, chromogranin, and synaptophysin [76]. The gene discussed is AR; the disease is prostate adenocarcinoma.